FDA Approves ORZEYFUL™, a First-in-Class Treatment for Adults With Narcolepsy Type 1
The U.S. Food and Drug Administration (FDA) has approved ORZEYFUL™ (oveporexton) for the treatment of narcolepsy type 1 (NT1), also known as narcolepsy with cataplexy, in adults. […]
